ArticleTranslational cancer research2026
The risk factors and patterns for distant metastasis in early-stage cervical adenocarcinoma patients receiving radical surgery and adjuvant radiotherapy: the ATTRACT study.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cervical adenocarcinoma (ADC) accounts for 15-25% of cervical cancer cases and carries a higher risk of distant metastasis (DM) and a poorer prognosis than squamous cell carcinoma (SCC). However, the DM patterns and risk factors in ADC patients receiving radical surgery and postoperative radiotherapy (PORT) remain insufficiently characterized. This study aimed to explore the DM pattern and risk factors associated with DM in ADC patients receiving radical surgery and postoperative radiotherapy. Methods: Patients with pathologically confirmed ADC after radical surgery were selected. The DM pattern was described using a metastatic organ distribution map. Survival outcomes were estimated using the Kaplan-Meier method, and intergroup differences were compared using the log-rank test. Risk factors for DM were identified through Cox regression analysis. A restricted cubic spline (RCS) curve was used to evaluate the association between the odds ratio (OR) for DM and cumulative platinum dose throughout treatment. Results: The most prevalent DM organ was the lung (51.1%), followed by liver (26.7%) and bone (24.4%). No significant difference regarding 5-year overall survival (OS) was observed between patients with single-site DM and those with multiple-site DM (44.2% Conclusions: The most common DM site for ADC patients after surgery and adjuvant radiotherapy was the lung. The risk factors for DM in those patients were LNM and DOI ≥1/2. Additionally, the prevention of DM could not be simply achieved by increasing the platinum dose during the primary treatment period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.